Global PD-L1 and PIK3CA Testing Market Research Report 2026

PD-L1 and PIK3CA Testing Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances. Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart). PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies. PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations. PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.

The global PD-L1 and PIK3CA testing market is experiencing robust growth, driven by the expanding use of precision oncology and the approval of targeted therapies across various cancer types, including NSCLC, breast, and cervical cancers. The increasing demand for companion diagnostics (CDx) in tandem with immunotherapies and PI3K inhibitors is accelerating the adoption of PD-L1 IHC assays and PIK3CA mutation tests. Additionally, government-backed initiatives for cancer screening, advancements in next-generation sequencing (NGS) platforms, and the growing integration of biomarkers into clinical decision-making are fostering greater clinical reliance on these tests. Leading pharmaceutical companies are also investing heavily in clinical trials that necessitate biomarker-based patient stratification, further boosting market penetration.

Despite the growth, the PD-L1 and PIK3CA testing market faces several challenges. Variability in test interpretation, lack of assay standardization, and the complexity of tumor heterogeneity often lead to inconsistent clinical outcomes, hampering trust in testing results. Regulatory hurdles for companion diagnostics, especially in emerging markets, and the high cost of NGS-based platforms pose barriers to adoption. Moreover, reimbursement uncertainty and disparities in healthcare infrastructure limit access in low-to-middle-income regions. The market is also affected by the evolving landscape of oncology diagnostics, where novel biomarkers and multi-gene panels may shift clinical focus away from single-analyte tests like PD-L1 or PIK3CA.

This report delivers a comprehensive overview of the global PD-L1 and PIK3CA Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PD-L1 and PIK3CA Testing. The PD-L1 and PIK3CA Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist PD-L1 and PIK3CA Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of PD-L1 and PIK3CA Testing Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 PD-L1 Testing

1.2.3 PIK3CA Testing

1.3 Market by Application

1.3.1 Global PD-L1 and PIK3CA Testing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global PD-L1 and PIK3CA Testing Market Perspective (2021–2032)

2.2 Global PD-L1 and PIK3CA Testing Growth Trends by Region

2.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2021–2026)

2.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2027–2032)

2.3 PD-L1 and PIK3CA Testing Market Dynamics

2.3.1 PD-L1 and PIK3CA Testing Industry Trends

2.3.2 PD-L1 and PIK3CA Testing Market Drivers

2.3.3 PD-L1 and PIK3CA Testing Market Challenges

2.3.4 PD-L1 and PIK3CA Testing Market Restraints

3.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue

3.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2021–2026)

3.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2021–2026)

3.2 Global Top PD-L1 and PIK3CA Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by PD-L1 and PIK3CA Testing Revenue

3.4 Global PD-L1 and PIK3CA Testing Market Concentration Ratio

3.4.1 Global PD-L1 and PIK3CA Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-L1 and PIK3CA Testing Revenue in 2025

3.5 Global Key Players of PD-L1 and PIK3CA Testing Head Offices and Areas Served

3.6 Global Key Players of PD-L1 and PIK3CA Testing, Products and Applications

3.7 Global Key Players of PD-L1 and PIK3CA Testing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2021–2026)

4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2027–2032)

5.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2021–2026)

5.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2027–2032)

6.1 North America PD-L1 and PIK3CA Testing Market Size (2021–2032)

6.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2021–2026)

6.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe PD-L1 and PIK3CA Testing Market Size (2021–2032)

7.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2021–2026)

7.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2021–2032)

8.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2021–2026)

8.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America PD-L1 and PIK3CA Testing Market Size (2021–2032)

9.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2021–2026)

9.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2021–2032)

10.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2021–2026)

10.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction

11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.1.5 Agilent Technologies Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche PD-L1 and PIK3CA Testing Introduction

11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.2.5 Roche Recent Development

11.3 QIAGEN

11.3.1 QIAGEN Company Details

11.3.2 QIAGEN Business Overview

11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction

11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.3.5 QIAGEN Recent Development

11.4 EntroGen

11.4.1 EntroGen Company Details

11.4.2 EntroGen Business Overview

11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction

11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.4.5 EntroGen Recent Development

11.5 Amoy Diagnostics

11.5.1 Amoy Diagnostics Company Details

11.5.2 Amoy Diagnostics Business Overview

11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction

11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.5.5 Amoy Diagnostics Recent Development

11.6 ACCB Biotech

11.6.1 ACCB Biotech Company Details

11.6.2 ACCB Biotech Business Overview

11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction

11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2021–2026)

11.6.5 ACCB Biotech Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of PD-L1 Testing

 Table 3. Key Players of PIK3CA Testing

 Table 4. Global PD-L1 and PIK3CA Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 5. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 6. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million), 2021–2026

 Table 7. Global PD-L1 and PIK3CA Testing Market Share by Region (2021–2026)

 Table 8. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 9. Global PD-L1 and PIK3CA Testing Market Share by Region (2027–2032)

 Table 10. PD-L1 and PIK3CA Testing Market Trends

 Table 11. PD-L1 and PIK3CA Testing Market Drivers

 Table 12. PD-L1 and PIK3CA Testing Market Challenges

 Table 13. PD-L1 and PIK3CA Testing Market Restraints

 Table 14. Global PD-L1 and PIK3CA Testing Revenue by Players (US$ Million), 2021–2026

 Table 15. Global PD-L1 and PIK3CA Testing Market Share by Players (2021–2026)

 Table 16. Global Top PD-L1 and PIK3CA Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on PD-L1 and PIK3CA Testing Revenue, 2025

 Table 17. Ranking of Global Top PD-L1 and PIK3CA Testing Companies by Revenue (US$ Million) in 2025

 Table 18. Global 5 Largest Players Market Share by PD-L1 and PIK3CA Testing Revenue (CR5 and HHI), 2021–2026

 Table 19. Global Key Players of PD-L1 and PIK3CA Testing, Headquarters and Area Served

 Table 20. Global Key Players of PD-L1 and PIK3CA Testing, Products and Applications

 Table 21. Global Key Players of PD-L1 and PIK3CA Testing, Date of General Availability (GA)

 Table 22. Mergers and Acquisitions, Expansion Plans

 Table 23. Global PD-L1 and PIK3CA Testing Market Size by Type (US$ Million), 2021–2026

 Table 24. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2021–2026)

 Table 25. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 26. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2027–2032)

 Table 27. Global PD-L1 and PIK3CA Testing Market Size by Application (US$ Million), 2021–2026

 Table 28. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2021–2026)

 Table 29. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 30. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2027–2032)

 Table 31. North America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2021–2026

 Table 33. North America PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2027–2032

 Table 34. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2021–2026

 Table 36. Europe PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2027–2032

 Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (US$ Million), 2021–2026

 Table 39. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (US$ Million), 2027–2032

 Table 40. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2021–2026

 Table 42. Latin America PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2027–2032

 Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2021–2026

 Table 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (US$ Million), 2027–2032

 Table 46. Agilent Technologies Company Details

 Table 47. Agilent Technologies Business Overview

 Table 48. Agilent Technologies PD-L1 and PIK3CA Testing Product

 Table 49. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 50. Agilent Technologies Recent Development

 Table 51. Roche Company Details

 Table 52. Roche Business Overview

 Table 53. Roche PD-L1 and PIK3CA Testing Product

 Table 54. Roche Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 55. Roche Recent Development

 Table 56. QIAGEN Company Details

 Table 57. QIAGEN Business Overview

 Table 58. QIAGEN PD-L1 and PIK3CA Testing Product

 Table 59. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 60. QIAGEN Recent Development

 Table 61. EntroGen Company Details

 Table 62. EntroGen Business Overview

 Table 63. EntroGen PD-L1 and PIK3CA Testing Product

 Table 64. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 65. EntroGen Recent Development

 Table 66. Amoy Diagnostics Company Details

 Table 67. Amoy Diagnostics Business Overview

 Table 68. Amoy Diagnostics PD-L1 and PIK3CA Testing Product

 Table 69. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 70. Amoy Diagnostics Recent Development

 Table 71. ACCB Biotech Company Details

 Table 72. ACCB Biotech Business Overview

 Table 73. ACCB Biotech PD-L1 and PIK3CA Testing Product

 Table 74. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (US$ Million), 2021–2026

 Table 75. ACCB Biotech Recent Development

 Table 76. Research Programs/Design for This Report

 Table 77. Key Data Information from Secondary Sources

 Table 78. Key Data Information from Primary Sources

 Table 79. Authors List of This Report

List of Figures

 Figure 1. PD-L1 and PIK3CA Testing Picture

 Figure 2. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global PD-L1 and PIK3CA Testing Market Share by Type: 2025 vs 2032

 Figure 4. PD-L1 Testing Features

 Figure 5. PIK3CA Testing Features

 Figure 6. Global PD-L1 and PIK3CA Testing Market Size by Application (US$ Million), 2021–2032

 Figure 7. Global PD-L1 and PIK3CA Testing Market Share by Application: 2025 vs 2032

 Figure 8. Hospital Case Studies

 Figure 9. Diagnostic Center Case Studies

 Figure 10. Others Case Studies

 Figure 11. PD-L1 and PIK3CA Testing Report Years Considered

 Figure 12. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 13. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 14. Global PD-L1 and PIK3CA Testing Market Share by Region: 2025 vs 2032

 Figure 15. Global PD-L1 and PIK3CA Testing Market Share by Players in 2025

 Figure 16. Global PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 17. The Top 10 and 5 Players Market Share by PD-L1 and PIK3CA Testing Revenue in 2025

 Figure 18. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 19. North America PD-L1 and PIK3CA Testing Market Share by Country (2021–2032)

 Figure 20. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 21. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 22. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 23. Europe PD-L1 and PIK3CA Testing Market Share by Country (2021–2032)

 Figure 24. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 25. France PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 26. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 27. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 28. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 29. Ireland PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Region (2021–2032)

 Figure 32. China PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 33. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 35. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 36. India PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. Australia & New Zealand PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2021–2032)

 Figure 40. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 41. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2021–2032)

 Figure 44. Israel PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 45. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. UAE PD-L1 and PIK3CA Testing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 47. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 48. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 49. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 50. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 51. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 52. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2021–2026)

 Figure 53. Bottom-up and Top-down Approaches for This Report

 Figure 54. Data Triangulation

 Figure 55. Key Executives Interviewed